Chemical Namecannabidiol
Dosage FormSolution (oral; 100 mg/mL)
Drug ClassMiscellaneous
CompanyGreenwich Biosciences
Approval Year2018


  • Epidiolex is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous sclerosis complex in patients 1 year of age and older.
Last updated on 10/22/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Epidiolex (cannabidiol) Prescribing Information2020Greenwich Biosciences